| Terminated | 1 | 132 | Europe, Canada, US | SEA-TGT, SGN-TGT, sasanlimab, brentuximab vedotin, Adcetris | Seagen Inc. | Non-small Cell Lung Cancer, Gastric Carcinoma, Gastroesophageal Junction Carcinoma, Classical Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma, Peripheral T-cell Lymphoma, Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma, Bladder Cancer, Ovarian Cancer, Triple Negative Breast Cancer, Cervical Cancer | 12/23 | 12/23 | | |